Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma and microneedling could potentially help hair growth in people with alopecia areata, but more research is needed.

Stem cells could be a better treatment for hair loss by reactivating dormant hair follicles.

LLLT helps treat hair loss by increasing blood flow, reducing inflammation, and stimulating growth factors.

Use minoxidil or finasteride first, then try HairMax LaserComb if needed.

Use of cosmeceuticals during pregnancy and breastfeeding is not recommended due to insufficient safety data.

Current and new treatments for hair loss include topical minoxidil and oral finasteride, but results vary and new options are being explored.

Current treatments for androgenetic alopecia are complex and promising, but more research is needed.

Phenobarbital-loaded chitosan nanoparticles are promising for preventing hair loss from chemotherapy.

Jamogenin from plants may help hair growth and is a potential alternative to finasteride.

About 21% of tested hair loss supplements contained illegal synthetic drugs.

Finasteride toxicity information is limited, poor quality, and biased.

The ARTAS robotic system for hair restoration is efficient with fewer cuts than manual methods, but it's limited to certain hair types and can still leave scars.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Some medications can help increase sexual desire and function in women.

Cetuximab often causes skin rashes, and managing these is important for cancer treatment.

Surgical hair restoration involves moving hair from a non-balding area to a balding area, with the transplanted hair not subject to male pattern baldness. Medications can slow hair loss and regrow some hair, but successful treatment needs careful planning, skill, and ethical responsibility due to progressive hair loss and limited donor hair.

Low-level light therapy is FDA-approved for male pattern hair loss, increases hair count and strength, and is considered safe for use.

Finasteride's effectiveness on the frontal hair loss area is not well-studied or confirmed.

The document concludes that developing generic topical drugs requires ensuring they match the original in quality, composition, and structure, and often involves complex testing and regulatory steps.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Microneedles offer a promising, painless way to treat skin diseases but need improvements for better use.

Computer-aided methods can speed up COVID-19 drug discovery and help find new uses for existing drugs.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Nanoformulations improve drug delivery through the skin, reducing side effects and enhancing effectiveness.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

The document concludes that doctors should carefully consider off-label drug use in dermatology and always inform patients, while more research is needed on the safety and effectiveness of such practices.

Multitarget drugs are needed to better treat complex diseases.

Doctors should diagnose hair loss by examining the patient and possibly doing tests, and then treat it based on the type, which may prevent permanent hair loss.

Chitosan-decorated nanoparticles can improve skin delivery and reduce side effects of finasteride.

Polymeric nanoparticles show promise for treating skin diseases.